Abstract
Blocking the expression of integrin α2β1, which was accomplished by transduction of α2-specific shRNA, resulted in significant inhibition of proliferation and clonal activity in human MCF-7 breast carcinoma and SK-Mel-147 melanoma cells. Along with these changes, deprivation of α2β1 caused a sharp decrease in melanoma cell invasion in vitro. Analysis of integrin-mediating signal pathways that control cell behavior revealed a significant increase in activity of Akt protein kinase in response to depletion of α2β1. The increase in Akt activity that accompanies a suppressive effect on cell invasion contradicts well-known Akt function aimed at stimulation of tumor progression. This contradiction could be explained by the “reversed” (noncanonical) role played by Akt in some cells that consists in suppression rather than promotion of invasive phenotype. To test this suggestion, the effects of Akt inhibitors on invasive activity of SK-Mel-147 cells were investigated. If the above suggestion is true, then inhibition of Akt in cells depleted of α2β1 should result in the restoration of their invasive activity. It appeared that treatment with LY294002, which inhibits all Akt isoforms (Akt1, Akt2, Akt3), not only failed to restore the invasive phenotype of melanoma cells but further attenuated their invasive activity. However, treatment of the cells with an Akt1-specific inhibitor significantly increased their invasion. Thus, the stimulating effect of α2β1 integrin on invasion of melanoma cells is realized through a mechanism based on inhibition of one of the Akt isoforms, which in these cells exhibits a noncanonical function consisting in suppression of invasion.
Similar content being viewed by others
Abbreviations
- ECM:
-
extracellular matrix
- EdU:
-
5-ethynyl-2′-deoxyuridine
References
Guo, W., and Giancotti, F. G. (2004) Integrin signalling during tumour progression, Nat. Rev. Mol. Cell. Biol., 10, 816–826.
Hehlgans, S., Haase, M., and Cordes, N. (2007) Signalling via integrins: implications for cell survival and anticancer strategies, Biochim. Biophys. Acta, 1775, 163–180.
Desgrosellier, J. S., and Cheresh, D. A. (2010) Integrins in cancer: biological implications and therapeutic opportunities, Nat. Rev. Cancer, 10, 9–22.
Kuphal, S., Bauer, R., and Bosserhoff, A. K. (2005) Integrin signaling in malignant melanoma, Cancer Metastasis Rev., 24, 195–222.
Haenssen, K. K., Caldwell, S. A., Shahriari, K. S., Jackson, S. R., Whelan, K. A., Klein-Szanto, A. J., and Reginato, M. J. (2010) ErbB2 requires integrin alpha 5 for anoikis resistance via Src regulation of receptor activity in human mammary epithelial cells, J. Cell Sci., 123, 1373–1382.
Bai, J., Zhang, J., Wu, J., Shen, L., Zeng, J., Ding, J., Wu, Y., Gong, Z., Li, A., Xu, S., Zhou, J., and Li, G. (2010) JWA regulates melanoma metastasis by integrin alphaVbeta 3 signaling, Oncogene, 29, 1227–1237.
Nam, E. H., Lee, Y., Moon, B., Lee, J. W., and Kim, S. (2015) Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial–mes-enchymal transition, Carcinogenesis, 36, 327–337.
Tran, T., Barlow, B., O’Rear, L., Jarvis, B., Li, Z., Dickeson, K., Dupont, W., and Zutter, M. (2011) Loss of the α2β1 integrin alters human papilloma virus-induced squamous carcinoma progression in vivo and in vitro, PLoS One, 6, e26858.
Girotti, M. R., Fernandez, M., Lopez, J. A., Camafeita, E., Fernandez, E. A., Albar, J. P., Benedetti, L. G., Valacco, M. P., Brekken, R. A., Podhajcer, O. L., and Llera, A. S. (2011) SPARC promotes cathepsin B-mediat-ed melanoma invasiveness through a collagen I/α2β1 inte-grin axis, J. Invest. Dermatol., 131, 2438–2447.
Burnier, J. V., Wang, N., Michel, R. P., Hassanain, M., Li, S., Lu, Y., Metrakos, P., Antecka, E., Burnier, M. N., Ponton, A., Gallinger, S., and Brodt, P. (2011) Type IV col-lagen-initiated signals provide survival and growth cues required for liver metastasis, Oncogene, 30, 3766–3783.
Li, X., Ishihara, S., Yasuda, M., Nishioka, T., Mizutani, T., Ishikawa, M., Kawabata, K., Shirato, H., and Haga, H. (2013) Lung cancer cells that survive ionizing radiation show increased integrin α2β1-and EGFR-dependent inva-siveness, PLoS One, 8, e70905.
Ramirez, N. E., Zhang, Z., Madamanchi, A., Boyd, K. L., O’Rear, L. D., Nashabi, A., Li, Z., Dupont, W. D., Zijlstra, A., and Zutter, M. M. (2011) The α2β1 integrin is a metas-tasis suppressor in mouse models and human cancer, J. Clin. Invest., 121, 226–237.
Ferraro, A., Mourtzoukou, D., Kosmidou, V., Avlonitis, S., Kontogeorgos, G., Zografos, G., and Pintzas, A. (2013) EZH2 is regulated by ERK/AKT and targets integrin alpha2 gene to control epithelial–mesenchymal transition and anoikis in colon cancer cells, Int. J. Biochem. Cell Biol., 45, 243–254.
Naci, D., Vuori, K., and Aoudjit, F. (2015) Alpha2beta1 integrin in cancer development and chemoresistance, Semin. Cancer Biol., 35, 145–153.
Guo, Y. S., Zhao, R., Ma, J., Cui, W., Sun, Z., Gao, B., He, S., Han, Y. H., Fan, J., Yang, L., Tang, J., and Luo, Z. J. (2014) βig-h3 promotes human osteosarcoma cells metastasis by interacting with integrin α2β1 and activating PI3K signaling pathway, PLoS One, 9, e90220.
Naci, D., Azreq, M. A., Chetoui, N., Lauden, L., Sigaux, F., Charron, D., Al-Daccak, R., and Aoudjit, F. (2012) α2β1 integrin promotes chemoresistance against doxoru-bicin in cancer cells through extracellular signal-regulated kinase (ERK), J. Biol. Chem., 287, 17065–17076.
Mannava, S., Omilian, A. R., Wawrzyniak, J. A., Fink, E. E., Zhuang, D., Miecznikowski, J. C., Marshall, J. R., Soengas, M. S., Sears, R. C., Morrison, C. D., and Nikiforov, M. A. (2012) PP2A-B56a controls oncogene-induced senescence in normal and tumor human melanocytic cells, Oncogene, 31, 1484–1492.
Morozevich, G. E., Kozlova, N. I., Ushakova, N. A., Preobrazhenskaya, M. E., and Berman, A. E. (2012) Integrin α5β1 simultaneously controls EGFR-dependent proliferation and Akt-dependent pro-survival signaling in epidermoid carcinoma cells, Aging (Albany NY), 4, 368–374.
Morozevich, G. E., Kozlova, N. I., Cheglakov, I. B., Ushakova, N. A., and Berman, A. E. (2009) Integrin α5β1 controls invasion of human breast carcinoma cells by direct and indirect modulation of MMP-2 collagenase activity, Cell Cycle, 14, 2219–2225.
Morozevich, G. E., Kozlova, N. I., Susova, O. Y., Karalkin, P. A., and Berman, A. E. (2015) Implication of α2β1 integrin in anoikis of MCF-7 breast carcinoma cells, Biochemistry (Moscow), 80, 97–103.
Krueger, J. S., Keshamouni, V. G., Atanaskova, N., and Reddy, K. B. (2001) Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion, Oncogene, 20, 4209–4218.
Okayama, H. (2012) Cdc6: a trifunctional AAA+ ATPase that plays a central role in controlling the G(1)-S transition and cell survival, J. Biochem., 152, 297–303.
Benetatos, L., Vartholomatos, G., and Hatzimichael, E. (2014) Polycomb group proteins and MYC: the cancer con-nection, Cell. Mol. Life Sci., 71, 257–269.
Toulany, M., and Rodemann, H. P. (2016) Phosphatidylinositol 3-kinase/Akt signaling as a key medi-ator of tumor cell responsiveness to radiation, Semin. Cancer Biol., 35, 180–190.
Safdari, Y., Khalili, M., Ebrahimzadeh, M. A., Yazdani, Y., and Farajnia, S. (2015) Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action, Pharmacol. Res., 93, 1–10.
Toker, A., and Yoeli-Lerner, M. (2006) Akt signaling and cancer: surviving but not moving on, Cancer Res., 66, 3963–3966.
Irie, H. Y., Pearline, R. V., Grueneberg, D., Hsia, M., Ravichandran, P., Kothari, N., Natesan, S., and Brugge, J. S. (2005) Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial–mesenchymal transition, J. Cell Biol., 19, 1023–1034.
Dyce, O. H., Ziober, A. F., Weber, R. S., Miyazaki, K., Khariwala, S. S., Feldman, M., and Ziober, B. L. (2002) Integrins in head and neck squamous cell carcinoma inva-sion, Laryngoscope, 112, 2025–2032.
Sottnik, J. L., Daignault-Newton, S., Zhang, X., Morrissey, C., Hussain, M. H., Keller, E. T., and Hall, C. L. (2013) Integrin alpha2beta1 (α2β1) promotes prostate cancer skeletal metastasis, Clin. Exp. Metastasis, 30, 569–578.
Yoshimura, K., Meckel, K. F., Laird, L. S., Chia, C. Y., Park, J. J., Olino, K. L., Tsunedomi, R., Harada, T., Iizuka, N., Hazama, S., Kato, Y., Keller, J. W., Thompson, J. M., Chang, F., Romer, L. H., Jain, A., Iacobuzio-Donahue, C., Oka, M., Pardoll, D. M., and Schulick, R. D. (2009) Integrin alpha2 mediates selective metastasis to the liver, Cancer Res., 69, 7320–7328.
Choi, J. A., Jung, Y. S., Kim, J. Y., Kim, H. M., and Lim, I. K. (2016) Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes, Oncogene, 35, 83–93.
Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R., and Muller, W. J. (2004) Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion, Cancer Res., 64, 3171–3178.
Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y., and Slamon, D. J. (2003) Overexpression of Akt2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells, Cancer Res., 63, 196–206.
Riggio, M., Perrone, M. C., Polo, M. L., Rodriguez, M. J., May, M., Abba, M., Lanari, C., and Novaro, V. (2017) AKT1 and AKT2 isoforms play distinct roles during breast cancer progression through the regulation of specific down-stream proteins, Sci. Rep., 7; doi: 10.1038/srep44244.
Rao, G., Pierobon, M., Kim, I. K., Hsu, W. H., Deng, J., Moon, Y.-W., Petricoin, E. F., Zhang, Y. W., Wang, Y., and Giaccone, G. (2017) Inhibition of AKT1 signaling pro-motes invasion and metastasis of non-small cell lung cancer cells with K-ras or EGFR mutations, Sci. Rep., 7; doi: 10.1038/s41598-017-06128-9.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2018, Vol. 83, No. 6, pp. 939-948.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM18-007, April 9, 2018.
Rights and permissions
About this article
Cite this article
Kozlova, N.I., Morozevich, G.E., Ushakova, N.A. et al. Implication of Integrin α2β1 in Proliferation and Invasion of Human Breast Carcinoma and Melanoma Cells: Noncanonical Function of Akt Protein Kinase. Biochemistry Moscow 83, 738–745 (2018). https://doi.org/10.1134/S0006297918060111
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297918060111